MRC1 and neoplasm: Then CD86 (M1 macrophage marker) and CD206 (M2 macrophage marker) were determined using flow cytometry, which showed that overexpression of JMJD1C resulted in a decrease of CD206+ cells and an increase of CD86+ cells in tumor tissues (Figure 2G).